{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:39:47Z","timestamp":1792179587303,"version":"4.4.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ajog.2019.05.018","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T11:48:11Z","timestamp":1558352891000},"page":"320.e1-320.e23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing"],"prefix":"10.1016","volume":"221","author":[{"given":"Aymara","family":"Mas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Garrido-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Escorcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Jim\u00e9nez-Almaz\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Pellicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Monle\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2019.05.018_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.05.018_bib2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.fertnstert.2007.01.093","article-title":"Etiology, symptomatology, and diagnosis of uterine myomas","volume":"87","author":"Parker","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2019.05.018_bib3","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2019.05.018_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2019.05.018_bib5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ajog.2017.08.019","article-title":"Focus on uterine fibroids: evolving options to optimize care","volume":"217","author":"Singh","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.05.018_bib6","first-page":"CD004638","article-title":"Minimally invasive surgical techniques versus open myomectomy for uterine fibroids","volume":"10","author":"Bhave Chittawar","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2019.05.018_bib7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jmig.2016.01.021","article-title":"Morcellator\u2019s port-site metastasis of a uterine smooth muscle tumor of uncertain malignant potential after minimally invasive myomectomy","volume":"23","author":"Bogani","year":"2016","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.ajog.2019.05.018_bib8","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/aogs.12930","article-title":"Uterine leiomyosarcoma\u2013incidence, treatment, and the impact of morcellation: a nationwide cohort study","volume":"95","author":"Skorstad","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2019.05.018_bib9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0090-8258(03)00137-9","article-title":"Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy","volume":"89","author":"Giuntoli","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.05.018_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3892\/mco.2013.124","article-title":"The biology of uterine sarcomas: a review and update","volume":"1","author":"Kobayashi","year":"2013","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ajog.2019.05.018_bib11","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1245\/s10434-012-2834-0","article-title":"Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution\u2019s experience","volume":"20","author":"Lusby","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajog.2019.05.018_bib12","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(09)70226-8","article-title":"Clinical management of uterine sarcomas","volume":"10","author":"Amant","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2019.05.018_bib13","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ajog.2018.01.006","article-title":"Peritoneal sarcomatosis 5 years after laparoscopic morcellation of uterine leiomyoma","volume":"218","author":"Petrillo","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.05.018_bib14","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2017.09.014","article-title":"Discussing sarcoma risks during informed consent for nonhysterectomy management of fibroids: an unmet need","volume":"218","author":"Seagle","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.05.018_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmig.2014.08.781","article-title":"Outcome of occult uterine leiomyosarcoma after surgery for presumed uterine fibroids: a systematic review","volume":"22","author":"Pritts","year":"2015","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.ajog.2019.05.018_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jmig.2015.12.012","article-title":"An open letter to the Food and Drug Administration regarding the use of morcellation procedures in women having surgery for presumed uterine myomas","volume":"23","author":"Parker","year":"2016","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.ajog.2019.05.018_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/IGC.0000000000000911","article-title":"European Society of Gynecological Oncology statement on fibroid and uterine morcellation","volume":"27","author":"Halaska","year":"2017","journal-title":"Int\u00a0J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2019.05.018_bib18","author":"Levitz"},{"key":"10.1016\/j.ajog.2019.05.018_bib19","doi-asserted-by":"crossref","first-page":"j2827","DOI":"10.1136\/bmj.j2827","article-title":"Amy Josephine Reed","volume":"357","author":"Roehr","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2019.05.018_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jogoh.2018.05.015","article-title":"Can the risks associated with uterine sarcoma morcellation really be prevented? Overview of the role of uterine morcellation in 2018","volume":"47","author":"Rousseau","year":"2018","journal-title":"J\u00a0Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.ajog.2019.05.018_bib21","doi-asserted-by":"crossref","first-page":"259.e1","DOI":"10.1016\/j.ajog.2016.11.1039","article-title":"Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroids: an updated decision analysis following the 2014 Food and Drug Administration safety communications","volume":"216","author":"Siedhoff","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.05.018_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10397-015-0878-4","article-title":"Options on fibroid morcellation: a literature review","volume":"12","author":"Br\u00f6lmann","year":"2015","journal-title":"Gynecol Surg"},{"key":"10.1016\/j.ajog.2019.05.018_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jmig.2013.11.011","article-title":"Imaging for uterine myomas and adenomyosis","volume":"21","author":"Shwayder","year":"2014","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.ajog.2019.05.018_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jog.12915","article-title":"Differential diagnosis between uterine sarcoma and leiomyoma using preoperative clinical characteristics","volume":"42","author":"Cho","year":"2016","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2019.05.018_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2214\/AJR.11.7287","article-title":"Uterine sarcomas: then and now","volume":"199","author":"Shah","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ajog.2019.05.018_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ygyno.2005.09.055","article-title":"Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma","volume":"101","author":"Leiser","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.05.018_bib27","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/modpathol.2012.203","article-title":"MED12 mutations in leiomyosarcoma and extrauterine leiomyoma","volume":"26","author":"Ravegnini","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajog.2019.05.018_bib28","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","article-title":"MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma","volume":"27","author":"Bertsch","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajog.2019.05.018_bib29","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.humpath.2014.04.012","article-title":"Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics","volume":"45","author":"Jour","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajog.2019.05.018_bib30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.fertnstert.2014.06.050","article-title":"Genomics of uterine leiomyomas: insights from high-throughput sequencing","volume":"102","author":"Mehine","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2019.05.018_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12943-017-0672-1","article-title":"Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors","volume":"16","author":"M\u00e4kinen","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ajog.2019.05.018_bib32","doi-asserted-by":"crossref","first-page":"e1005850","DOI":"10.1371\/journal.pgen.1005850","article-title":"Exome sequencing of uterine leiomyosarcomas identifies frequent mutations in TP53, ATRX, and MED12","volume":"12","author":"M\u00e4kinen","year":"2016","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ajog.2019.05.018_bib33","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ijc.31129","article-title":"Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways","volume":"142","author":"Cuppens","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2019.05.018_bib34","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S1470-2045(15)00375-7","article-title":"Morcellation of uterine leiomyomas: a plea for patient triage","volume":"16","author":"Amant","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2019.05.018_bib35","series-title":"Tumours of the breast and female genital organs","first-page":"233","article-title":"Mesenchymal tumours and related lesions","author":"Hendrickson","year":"2003"},{"key":"10.1016\/j.ajog.2019.05.018_bib36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/his.12267","article-title":"The evolving classification of soft tissue tumours: an update based on the new 2013 WHO classification","volume":"64","author":"Fletcher","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.ajog.2019.05.018_bib37","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/bioinformatics\/bty849","article-title":"Pisces: an accurate and versatile variant caller for somatic and germline next-generation sequencing data","volume":"35","author":"Dunn","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajog.2019.05.018_bib38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajog.2019.05.018_bib39","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol"},{"key":"10.1016\/j.ajog.2019.05.018_bib40","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/JTO.0000000000000461","article-title":"ALK FISH and IHC: you cannot have one without the other","volume":"10","author":"Yatabe","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.ajog.2019.05.018_bib41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.lungcan.2015.05.012","article-title":"Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended","volume":"89","author":"Savic","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ajog.2019.05.018_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2004.11.009","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyosarcoma","volume":"161","author":"Sandberg","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.ajog.2019.05.018_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.06.013","article-title":"Genetic aberrations in soft tissue leiomyosarcoma","volume":"275","author":"Yang","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajog.2019.05.018_bib44","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00432-012-1182-6","article-title":"Analysis of molecular cytogenetic alterations in uterine leiomyosarcoma by array-based comparative genomic hybridization","volume":"138","author":"Raish","year":"2012","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.ajog.2019.05.018_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9440(10)63091-X","article-title":"Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors","volume":"164","author":"Lehtonen","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajog.2019.05.018_bib46","doi-asserted-by":"crossref","first-page":"e40015","DOI":"10.1371\/journal.pone.0040015","article-title":"MED12 alterations in both human benign and malignant uterine soft tissue tumors","volume":"7","author":"P\u00e9rot","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2019.05.018_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1302736","article-title":"Characterization of uterine leiomyomas by whole-genome sequencing","volume":"369","author":"Mehine","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2019.05.018_bib48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/cjp2.11","article-title":"Loss of ATRX and DAXX expression identifies poor prognosis for smooth muscle tumours of uncertain malignant potential and early stage uterine leiomyosarcoma","volume":"1","author":"Slatter","year":"2015","journal-title":"J\u00a0Pathol Clin Res"},{"key":"10.1016\/j.ajog.2019.05.018_bib49","doi-asserted-by":"crossref","first-page":"243298","DOI":"10.1155\/2015\/243298","article-title":"Potential therapeutic targets in uterine sarcomas","volume":"2015","author":"Cuppens","year":"2015","journal-title":"Sarcoma"},{"key":"10.1016\/j.ajog.2019.05.018_bib50","doi-asserted-by":"crossref","first-page":"e83859","DOI":"10.1371\/journal.pone.0083859","article-title":"Identification of candidate driver genes in common focal chromosomal aberrations of microsatellite stable colorectal cancer","volume":"8","author":"Burghel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2019.05.018_bib51","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/JTO.0000000000000109","article-title":"ALK\/EML4 fusion gene may be found in pure squamous carcinoma of the lung","volume":"9","author":"Cali\u00f2","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.ajog.2019.05.018_bib52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.lungcan.2016.10.010","article-title":"Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers","volume":"102","author":"Chapman","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ajog.2019.05.018_bib53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/ijc.IJC_72_17","article-title":"New insights into anaplastic lymphoma kinase-positive nonsmall cell lung cancer","volume":"54","author":"Dubey","year":"2017","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.ajog.2019.05.018_bib54","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/PAS.0000000000000909","article-title":"Inflammatory myofibroblastic tumors of the female\u00a0genital tract are under-recognized: a\u00a0low\u00a0threshold for ALK immunohistochemistry is required","volume":"41","author":"Pickett","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2019.05.018_bib55","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAS.0000000000000593","article-title":"Myxoid leiomyosarcoma of the uterus: a clinicopathologic analysis of 30 cases and review of the literature with reappraisal of its distinction from other uterine myxoid mesenchymal neoplasms","volume":"40","author":"Parra-Herran","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2019.05.018_bib56","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1111\/j.1582-4934.2008.00427.x","article-title":"\u201cPax genes in embryogenesis and oncogenesis\u201d: review","volume":"12","author":"Wang","year":"2008","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.ajog.2019.05.018_bib57","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.fertnstert.2016.10.035","article-title":"Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays","volume":"107","author":"Yatsenko","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2019.05.018_bib58","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1038\/onc.2009.259","article-title":"The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene","volume":"28","author":"Chua","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.ajog.2019.05.018_bib59","doi-asserted-by":"crossref","first-page":"224ra224","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajog.2019.05.018_bib60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature07638","article-title":"Transcriptome sequencing to detect gene fusions in cancer","volume":"458","author":"Maher","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2019.05.018_bib61","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nbt.3080","article-title":"A\u00a0comprehensive transcriptional portrait of human cancer cell lines","volume":"33","author":"Klijn","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajog.2019.05.018_bib62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2017.12.010","article-title":"Phosphoinositide 3-kinase inhibitors in advanced breast cancer: a systematic review and meta-analysis","volume":"91","author":"Raphael","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajog.2019.05.018_bib63","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10549-018-4697-y","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in triple-negative breast cancer: a review","volume":"169","author":"Costa","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajog.2019.05.018_bib64","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2019.05.018_bib65","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.ajog.2019.05.018_bib66","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAT.0000000000000114","article-title":"Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer","volume":"46","author":"Houang","year":"2014","journal-title":"Pathology"},{"key":"10.1016\/j.ajog.2019.05.018_bib67","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1093\/nar\/gkr988","article-title":"KEGG for integration and interpretation of large-scale molecular data sets","volume":"40","author":"Kanehisa","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajog.2019.05.018_bib68","series-title":"ggplot2: elegant graphics for data analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.ajog.2019.05.018_bib69","author":"Wickham"},{"key":"10.1016\/j.ajog.2019.05.018_bib70","author":"Chen"},{"key":"10.1016\/j.ajog.2019.05.018_bib71","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1093\/bioinformatics\/btu168","article-title":"VariantAnnotation: a Bioconductor package for exploration and annotation of genetic variants","volume":"30","author":"Obenchain","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajog.2019.05.018_bib72","doi-asserted-by":"crossref","first-page":"986048","DOI":"10.1155\/2014\/986048","article-title":"Advanced heat map and clustering analysis using heatmap3","volume":"2014","author":"Zhao","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ajog.2019.05.018_bib73","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nmeth.3252","article-title":"Orchestrating high-throughput genomic analysis with Bioconductor","volume":"12","author":"Huber","year":"2015","journal-title":"Nat Methods"},{"key":"10.1016\/j.ajog.2019.05.018_bib74","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrc3090","article-title":"Cyclin D as a therapeutic target in cancer","volume":"11","author":"Musgrove","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajog.2019.05.018_bib75","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2119\/2007-00101.YU","article-title":"Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas","volume":"14","author":"Yu","year":"2008","journal-title":"Mol Med"},{"key":"10.1016\/j.ajog.2019.05.018_bib76","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajog.2019.05.018_bib77","doi-asserted-by":"crossref","first-page":"260","DOI":"10.20892\/j.issn.2095-3941.2015.0102","article-title":"Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients","volume":"13","author":"Zhou","year":"2016","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.ajog.2019.05.018_bib78","first-page":"297","article-title":"Molecular mechanisms of uterine leiomyosarcomas: involvement of defect in LMP2 expression","volume":"2","author":"Hayashi","year":"2008","journal-title":"Gene Regul Syst Bio"},{"key":"10.1016\/j.ajog.2019.05.018_bib79","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/s41598-017-02912-9","article-title":"Oncopig Soft-Tissue Sarcomas Recapitulate Key Transcriptional Features of Human Sarcomas","volume":"7","author":"Schachtschneider","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2019.05.018_bib80","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1158\/1535-7163.MCT-17-0040","article-title":"CDK4\/6 Inhibitors Sensitize Rb-positive Sarcoma Cells to Wee1 Kinase Inhibition through Reversible Cell-Cycle Arrest","volume":"16","author":"Francis","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ajog.2019.05.018_bib81","first-page":"3487","article-title":"The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors","volume":"8","author":"Zhan","year":"1988","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajog.2019.05.018_bib82","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.phrs.2016.03.024","article-title":"Blocking the FGF\/FGFR system as a \u201ctwo-compartment\u201d antiangiogenic\/antitumor approach in cancer therapy","volume":"107","author":"Giacomini","year":"2016","journal-title":"Pharmacol Res"},{"issue":"7","key":"10.1016\/j.ajog.2019.05.018_bib83","first-page":"701","article-title":"Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas","volume":"8","author":"Jeffers","year":"1995","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajog.2019.05.018_bib84","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pharmthera.2017.05.013","article-title":"Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach","volume":"179","author":"Presta","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ajog.2019.05.018_bib85","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.biocel.2007.03.022","article-title":"MDM2 and MDM4: p53 regulators as targets in anticancer therapy","volume":"39","author":"Toledo","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ajog.2019.05.018_bib86","doi-asserted-by":"crossref","first-page":"10236","DOI":"10.1073\/pnas.0901298106","article-title":"Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene","volume":"106","author":"Atwal","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2019.05.018_bib87","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000362523","article-title":"Array-CGH shows amplification of 8q including MYC as the sole aberration in a leiomyosarcoma of the female lower genital tract","volume":"142","author":"Barnabas","year":"2014","journal-title":"Cytogenet Genome Res"},{"key":"10.1016\/j.ajog.2019.05.018_bib88","doi-asserted-by":"crossref","first-page":"39254","DOI":"10.18632\/oncotarget.16845","article-title":"Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas","volume":"8","author":"Groisberg","year":"2017","journal-title":"Oncotarget"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819306763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819306763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:33:58Z","timestamp":1762079638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937819306763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0002937819306763"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2019.05.018","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2019.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}